---
title: L-Kynurenine participates in cancer immune evasion by downregulating hypoxic
  signaling in T lymphocytes
date: '2023-08-14'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37577144/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20230814181231&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: Malignant tumors often escape anticancer immune surveillance by suppressing
  the cytotoxic functions of T lymphocytes. While many of these immune evasion networks
  include checkpoint proteins, small molecular weight compounds, such as the amino
  acid L-kynurenine (LKU), could also substantially contribute to the suppression
  of anti-cancer immunity. However, the biochemical mechanisms underlying the suppressive
  effects of LKU on T-cells remain unclear. Here, we report for the first time that
  ...
disable_comments: true
---
Malignant tumors often escape anticancer immune surveillance by suppressing the cytotoxic functions of T lymphocytes. While many of these immune evasion networks include checkpoint proteins, small molecular weight compounds, such as the amino acid L-kynurenine (LKU), could also substantially contribute to the suppression of anti-cancer immunity. However, the biochemical mechanisms underlying the suppressive effects of LKU on T-cells remain unclear. Here, we report for the first time that ...